Related Experiment Video
Updated: Mar 27, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
HIV-Associated TB Syndemic: A Growing Clinical Challenge Worldwide
Maria Theresa Montales1, Arun Chaudhury2, Alexandria Beebe3
1University of Arkansas for Medical Sciences (UAMS) , Little Rock, AR , USA.
The syndemic of tuberculosis (TB) and human immunodeficiency virus (HIV) requires active screening for TB in people living with HIV. Early detection and treatment of TB in HIV patients are crucial for public health.
Area of Science:
- Infectious Diseases
- Public Health
- Global Health
Background:
- The co-occurrence of tuberculosis (TB) and human immunodeficiency virus (HIV) represents a significant and growing syndemic.
- People living with HIV (PLHIV) have a substantially higher risk of developing active TB disease from latent infection.
- Globalization and migration are increasing TB case detection in developed nations, not just endemic regions.
Purpose of the Study:
- To review the challenges and strategies for managing the TB-HIV syndemic.
- To emphasize the need for active TB screening in PLHIV.
- To highlight advancements in diagnostic tools and treatment recommendations.
Main Methods:
- Review of current literature on TB-HIV coinfection.
- Discussion of diagnostic challenges in paucibacillary TB among PLHIV.
- Evaluation of the role of GeneXPERT MTB/RIF assay in TB detection.
Main Results:
- HIV-Mycobacterium tuberculosis (MTB) coinfection is often difficult to diagnose with conventional methods.
- GeneXPERT MTB/RIF assay improves the detection of both pulmonary and extrapulmonary TB.
- The World Health Organization recommends immediate TB therapy alongside antiretroviral therapy.
Conclusions:
- Active TB screening in PLHIV is essential.
- A high index of suspicion for TB is warranted in PLHIV with relevant symptoms.
- Integrated HIV and TB services are a public health priority, especially in high-prevalence settings.
More Related Videos
15:28A Microscopic Phenotypic Assay for the Quantification of Intracellular Mycobacteria Adapted for High-throughput/High-content Screening
Published on: January 17, 2014
09:34An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Sexually Transmitted Infections